Drug induced granulopenia and agranulocytosis. A polycentric study conducted by the association of French Pharmacovigilance Centers
Sgro, C.; Escousse, A.; Dumas, M.; Guy, H.; Larcher, F.; Sattonet, C.; Giraud, C.
Therapie 37(4): 363-370
1982
ISSN/ISBN: 0040-5957 PMID: 7135315 Document Number: 184357
Document emailed within 1 workday
Related Documents
Lefebure, B.; Castot, A.; Danan, G.; Elmalem, J.; Jean-Pastor, M.J.; Efthymiou, M.L. 1984: Hepatitis from antidepressants. Evaluation of cases from the French Association of Drug Surveillance Centers and the Technical Committee Therapie 39(5): 509-516Bodiou, C.; Bavoux, F. 1988: Niaprazine and side effects in pediatrics. Cooperative evaluation of French centers of pharmacovigilance Therapie 43(4): 307-311
Imbs, J.L.; Pouyanne, P.; Haramburu, F.; Welsch, M.; Decker, N.; Blayac, J.P.; Bégaud, B. 1999: Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance Therapie 54(1): 21-27
Lavarenne, J.; Dumas, R.; Cayrol, C. 1983: Adverse effects of drugs in old people. Evaluation of cases received for a year at the French Association of Drug Monitoring Centers Therapie 38(5): 485-493
Netter, P.; Tréchot, P.; Bannwarth, B.; Faure, G.; Royer, R.J. 1985: Side effects of D-penicillamine and pyritinol. Cooperative study among French hospital drug surveillance centers Therapie 40(6): 475-479
Petit, A.; Piednoir, Dée.; Germain, M-Laure.; Trenque, T. 2003: Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database Therapie 58(2): 159-163
Tissier, M.H.; Lepagnol, F. 2002: Cosmetovigilance: a French pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future Therapie 57(3): 273-282
Pregowski, W. 1981: Results of a survey conducted in various Polish centers on the treatment effectiveness in active tuberculosis and drug resistance Pneumonologia Polska 49(7): 521-525
Lawińska-Stankiewiczowa; Wszelaczyńska-Szaszkiewi 1973: Drug-induced agranulocytosis Wiadomosci Lekarskie 26(16): 1497-1501
Kuhnowski, F.éd.ér.; Bauters, F. 2005: Management of drug-induced agranulocytosis La Revue du Praticien 55(6): 671-675
Płusa, T.; Frank-Piskorska, A.; Kaszyński, H. 1983: Lung abscess in drug-induced agranulocytosis Pneumonologia Polska 51(10): 525-530
Larger, E.; Hillaire-Buys, D.; Assan, R.; Blayac, J.P. 1995: Drug-induced hypoglycemia in 1995. Pharmacovigilance data, analysis of the literature Journees Annuelles de Diabetologie de l'Hotel-Dieu 1995: 89-105
Pavithran, K.; Thomas, M. 2002: Hematopoietic growth factors in drug-induced agranulocytosis Journal of the Association of Physicians of India 50(5): 679-681
Gracheva, N.M. 1974: Medicamentous agranulocytosis as a manifestation of drug induced disease Terapevticheskii Arkhiv 46(1): 98-105
Pisciotta, A.V. 1973: Immune and toxic mechanisms in drug-induced agranulocytosis Seminars in Hematology 10(4): 279-310
Mintz, U.; Shaklai, M.; Pinkhas, J.; de Vries, A. 1975: Drug-induced agranulocytosis. a survey of twenty-three episodes Medecine Interne 13(3): 205-208
Rose, M.S.; Leahy, M.F.; Stevens, A.; Black, P.J.; Barkhan, P. 1972: The bone marrow during recovery from drug induced agranulocytosis Guy's Hospital Reports 121(2): 147-153
Konopka, C.A. 1984: Evaluation of the clinical activity of azlocillin. a multicenter study conducted in 14 centers Presse Medicale 13(13): 808-811
Hospers, G.A.; de Wolf, J.T.; Hazenberg, B.P.; Vellenga, E. 1993: Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis Nederlands Tijdschrift Voor Geneeskunde 137(42): 2152-2154
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115